YOKOHAMA, Japan--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company ...
ALPHARETTA, Ga., March 30, 2026 (GLOBE NEWSWIRE) -- Micron Biomedical, a clinical stage company developing dissolvable, needle-free products that could replace injectable pharmaceuticals and vaccines, ...
NEW HOPE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (OBIO) (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies ...
In this article, we will look at the 15 highest paying countries for biomedical engineers. We have also discussed the global bioengineering technology market. If you want to skip our detailed analysis ...
SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a clinical-stage bioengineering company with a first-of-its-kind bone marrow banking platform for processing and deploying hematopoietic stem cells and ...
$106.5 million cash position as of December 31, 2025 to be further enhanced by $35 million expected from Medtronic and Ligand in Q2 2026 from previously announced transactions, as well as Haemonetics’ ...
Artificial intelligence is transforming biomedical science, accelerating research and revealing new tools for drug discovery and treatments for stubborn diseases. The University of Texas at Dallas has ...
Recognition as second most innovative smaller company across all industries highlights transformative impact on public health, impactful industry collaborations, and a novel manufacturing approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results